BIOSINTETICA FARMACEUTICA LTDA has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Brazil, Argentina and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are NOVEL PHARMA INC, SCICLONE PHARMACEUTICALS and ZENGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 5 | |
#2 | Argentina | 1 | |
#3 | China | 1 | |
#4 | Colombia | 1 | |
#5 | Ecuador | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Mexico | 1 | |
#8 | Peru | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Visconde Omilton Jr | 5 |
#2 | Falci Marcio | 4 |
#3 | Visconde Omilton Junior | 2 |
#4 | Gisele Picolo | 1 |
#5 | Katsuhiro Konno | 1 |
#6 | Trugo Luis Carlos | 1 |
#7 | Lima Darcy Roberto Andrade | 1 |
#8 | Yara Cury | 1 |
Publication | Filing date | Title |
---|---|---|
CN101848927A | Analgesic compounds | |
BRPI0204792A | Triple pharmaceutical combination for high blood pressure | |
BRPI0506066A | Composition for atherosclerotic disease | |
BRPI0505066A | pharmaceutical composition for hypertension | |
BRPI0505064A | antihypertensive association | |
BRPI0502523A | appropriate pharmacotechnique for combination drug normalizing blood pressure and cholesterol levels |